4.8 Editorial Material

Tumor-directed dysregulation of erythroid progenitors drives immunosuppressive myeloid cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy

Haixia Long et al.

Summary: This study reveals a mechanism by which tumors exploit anemia-triggered erythropoiesis for myeloid transdifferentiation and immunosuppression.

CANCER CELL (2022)

Review Oncology

Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic

Amit Grover et al.

Summary: MDSCs are important regulators of immune responses in cancer, and their association with negative clinical outcomes makes them attractive therapeutic targets. However, the complex nature of MDSC biology presents a substantial challenge for therapeutic targeting. This review discusses the challenges and potential solutions in targeting MDSCs for therapeutic intervention.

CANCER DISCOVERY (2021)

Review Multidisciplinary Sciences

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Vincenzo Bronte et al.

NATURE COMMUNICATIONS (2016)

Article Biochemistry & Molecular Biology

The Branching Point in Erythro-Myeloid Differentiation

Leila Perie et al.

Article Biochemistry & Molecular Biology

Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors

Franziska Paul et al.